Episode
Episode 270 | Franco Kraiselburd, Founder & CEO, Asclepii | Reimagining Wound Care Through Accessible Innovation
- Podcast
- Project Medtech
- Published
- Jul 20, 2026
- Duration seconds
- 2211
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/project-medtech-601743/episodes/episode-270-franco-kraiselburd-founder-ceo-asclepii-reimagining-wound-care-through-accessible-innovation/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/project-medtech-601743/episode-270-franco-kraiselburd-founder-ceo-asclepii-reimagining-wound-care-through-accessible-innovation.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
What if the biggest breakthrough in wound care is making advanced treatments simpler? In this episode, Franco Kraiselburd, founder of Asclepii, shares how mentorship from stem cell pioneer Arnold Kaplan inspired a mission to transform wound care through accessible innovation. He discusses the launch of Poseidon, an innovative silver nanoparticle hydrogel designed to improve healing while simplifying treatment, previews the future of Artemis, a next-generation collagen dressing, and reflects on the lessons he's learned building a medtech startup. From raising capital to bringing new technologies to market, Franco offers an inside look at what it takes to challenge the standard of care and deliver innovations that have the potential to improve outcomes for patients and providers alike. Ethan Kraiselburd LinkedIn Asclepii LinkedIn Innovators Dilemma by Clay Christensen The Hard Thing About Hard Things by Ben Horowitz Duane Mancini LinkedIn Project Medtech Website Project Medtech LinkedIn Thank you to our sponsors: Ward Law , Wheelhouse DMG , and JumpStart Inc .